These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1735777)

  • 21. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation.
    Sood SK; Daum RS
    Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States.
    Marshall GS; Marchant CD; Blatter M; Friedland LR; Aris E; Miller JM
    Hum Vaccin; 2011 Feb; 7(2):258-64. PubMed ID: 21307655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to a Haemophilus influenzae type b diphtheria CRM197 conjugate vaccine in children with a defect of antibody production to Haemophilus influenzae type b polysaccharide.
    Schneider LC; Insel RA; Howie G; Madore DV; Geha RS
    J Allergy Clin Immunol; 1990 May; 85(5):948-53. PubMed ID: 2332568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Avidities of hapten-specific antibodies when the responses are modulated by anti-carrier antibodies.
    Whited Collisson E; Andersson B; Lamon EW
    Immunology; 1984 Nov; 53(3):443-9. PubMed ID: 6386675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered.
    Daum RS; Zenko CE; Given GZ; Ballanco GA; Parikh H; Germino K
    J Infect Dis; 2001 Nov; 184(10):1293-9. PubMed ID: 11679918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation, antigenicity, and immunogenicity of synthetic ribosylribitol phosphate oligomer-protein conjugates and their potential use for vaccination against Haemophilus influenzae type b disease.
    Evenberg D; Hoogerhout P; van Boeckel CA; Rijkers GT; Beuvery EC; van Boom JH; Poolman JT
    J Infect Dis; 1992 Jun; 165 Suppl 1():S152-5. PubMed ID: 1588151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Qualitative and quantitative analyses of the antibody response elicited by Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in adults with IgG subclass deficiencies and frequent infections.
    Avanzini MA; Björkander J; Söderström R; Söderström T; Schneerson R; Robbins JB; Hanson LA
    Clin Exp Immunol; 1994 Apr; 96(1):54-8. PubMed ID: 8149666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells.
    Baker PJ; Prescott B; Stashak PW; Amsbaugh DF
    J Immunol; 1971 Sep; 107(3):719-24. PubMed ID: 4398381
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of a guinea pig model to assess interference in the immunogenicity of different components of a combination vaccine comprising diphtheria, tetanus and acellular pertussis (DTaP) vaccine and haemophilus influenzae type b capsular polysaccharide conjugate vaccine.
    Gupta RK; Anderson R; Cecchini D; Rost B; Xu J; Gendreau K; Saroff DL; Marchant C; Siber GR
    Biologicals; 1999 Jun; 27(2):167-76. PubMed ID: 10600208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulatory role of intravenous gammaglobulin (IgIV) on the in vitro antibody response to a pneumococcal polysaccharide antigen.
    Leiva LE; Monjure H; Sorensen RU
    J Clin Immunol; 2015 Feb; 35(2):206-12. PubMed ID: 25504423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines.
    Madore DV; Phipps DC; Eby R; Johnson CL; Smith DH
    Contrib Microbiol Immunol; 1989; 10():125-50. PubMed ID: 2684505
    [No Abstract]   [Full Text] [Related]  

  • 32. Polysaccharide conjugate vaccine protein carriers as a "neglected valency" - Potential and limitations.
    Bröker M; Berti F; Schneider J; Vojtek I
    Vaccine; 2017 Jun; 35(25):3286-3294. PubMed ID: 28487056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in children with sickle hemoglobinopathy or malignancies, and after systemic Haemophilus influenzae type b infection.
    Kaplan SL; Duckett T; Mahoney DH; Kennedy LL; Dukes CM; Schaffer DM; Mason EO
    J Pediatr; 1992 Mar; 120(3):367-70. PubMed ID: 1538281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of human B lymphocytes after immunization with pneumococcal polysaccharides.
    Kehrl JH; Fauci AS
    J Clin Invest; 1983 Apr; 71(4):1032-40. PubMed ID: 6339558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine.
    Eskola J; Olander RM; Hovi T; Litmanen L; Peltola S; Käyhty H
    Lancet; 1996 Dec 21-28; 348(9043):1688-92. PubMed ID: 8973430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Avidity maturation of antibody to Haemophilus influenzae type b (Hib) after immunization with diphtheria-tetanus-acellular pertussis-hib-hepatitis B combined vaccine in infants.
    Pichichero ME; Voloshen T; Zajac D; Passador S
    J Infect Dis; 1999 Oct; 180(4):1390-3. PubMed ID: 10479180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The intrinsic affinity constant (K) of anticapsular antibody to oligosaccharides of Haemophilus influenzae type b.
    Hetherington SV
    J Immunol; 1988 Jun; 140(11):3966-70. PubMed ID: 3259602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults.
    Schauer U; Stemberg F; Rieger CH; Büttner W; Borte M; Schubert S; Möllers H; Riedel F; Herz U; Renz H; Herzog W
    Clin Diagn Lab Immunol; 2003 Mar; 10(2):202-7. PubMed ID: 12626443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants.
    Wijmenga-Monsuur AJ; van Westen E; Knol MJ; Jongerius RM; Zancolli M; Goldblatt D; van Gageldonk PG; Tcherniaeva I; Berbers GA; Rots NY
    PLoS One; 2015; 10(12):e0144739. PubMed ID: 26658902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.